AP
ArtProtein Biologics CDMO

From sequence to scalable biologics.

ArtProtein partners with you to develop, scale, and characterize complex biologics using robust CHO/HEK platforms.

Platforms CHO / HEK
Focus mAbs & Proteins
Engagement End-to-end

What we do

Cell line development

Stable CHO/HEK cell lines engineered for multi-g/L productivity and manufacturability.

Process development

DoE-driven upstream and downstream processes designed for reliable tech transfer.

Analytics & quality

Fit-for-purpose analytical methods and characterization to support IND-ready dossiers.